Abstract
ABSTRACT: Multiple acyl-CoA dehydrogenation disorders result from generalized defects in intramitochondrial acyl-CoA dehydrogenation. Fibroblasts from a riboflavin-responsive multiple acyl-CoA dehydrogenation disorder patient catabolized 14C-butyrate, -octanoate, and -leucine normally after culture in riboflavin-supplemented medium (2 mg/L). After culture in riboflavin-depleted medium (≤1.4 μg/L), his cells oxidized the same substrates poorly at 20 to 33% of control (p < 0.05). Patient cells incubated in a wide range of d-[2-14C]riboflavin concentrations (3, 31.4, and 100 μg/L) synthesized 14C-flavin mononucleotide and 14C-flavin adenine dinucleotide (FAD) normally and had normal cytosolic 14C-flavin mononucleotide and 14C-FAD contents, which argues against defects in cellular riboflavin uptake and conversion to flavin mononucleotide and FAD. After culture in 31.4 μg 14C-riboflavin /L for 2 wk, 14C-FAD specific radioactivities plateaued and were similar in patient and control cells. However, culturing these uniformly labeled cells in riboflavin-depleted medium for 2 wk lowered the patient's cellular 14C-FAD content to only 23% of control levels. Similarly, after incubation in low 14C-riboflavin concentrations (4.4 μ g/L), the patient's mitochondrial 14C-FAD content was only 51% of control after 1 h and 29% of control at 4 h. After a 4-h incubation in a high physiologic concentration of 14C-riboflavin (31.4 μ g/L), which raised the patient's cellular 14C-FAD levels 3- to 4-fold, his mitochondrial 14C-FAD content rose to normal; control values did not change. We also investigated possible defective FAD binding to flavoenzymes essential for acyl-CoA dehydrogenation. Medium-chain acyl-CoA dehydrogenase activities did not fall significantly in either patient or control mitochondria from cells cultured in riboflavin-depleted medium. However, after culture in riboflavin-depleted medium, the patient's electron transfer flavoprotein activity fell to 59% of control in mitochondrial preparations, which is compatible with decreased matrix FAD content. We postulate that defective maintenance of mitochondrial FAD levels explains this patient's riboflavin-responsive multiple acyl-CoA dehydrogenation disorder phenotype.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rhead, W., Roettger, V., Marshali, T. et al. Multiple Acyl-Coenzyme A Dehydrogenation Disorder Responsive to Riboflavin: Substrate Oxidation, Flavin Metabolism, and Flavoenzyme Activities in Fibroblasts. Pediatr Res 33, 129–135 (1993). https://doi.org/10.1203/00006450-199302000-00008
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199302000-00008
This article is cited by
-
Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect
Neurological Sciences (2012)
-
Computational analysis of a novel mutation in ETFDH gene highlights its long-range effects on the FAD-binding motif
BMC Structural Biology (2011)
-
Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A
Journal of Molecular Medicine (2011)
-
Mitochondrial fatty acid oxidation defects—remaining challenges
Journal of Inherited Metabolic Disease (2008)